OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinically approved combination immunotherapy: Current status, limitations, and future perspective
Ligong Lu, Meixiao Zhan, Xian-Yang Li, et al.
Current Research in Immunology (2022) Vol. 3, pp. 118-127
Open Access | Times Cited: 45
Ligong Lu, Meixiao Zhan, Xian-Yang Li, et al.
Current Research in Immunology (2022) Vol. 3, pp. 118-127
Open Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
Nazeer Hasan, Arif Nadaf, Mohammad Imran, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 93
Nazeer Hasan, Arif Nadaf, Mohammad Imran, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 93
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
Ashley M. Holder, Aikaterini Dedeilia, Kailan Sierra-Davidson, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 7, pp. 498-512
Closed Access | Times Cited: 45
Ashley M. Holder, Aikaterini Dedeilia, Kailan Sierra-Davidson, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 7, pp. 498-512
Closed Access | Times Cited: 45
Endothelial cells in tumor microenvironment: insights and perspectives
Patrizia Leone, Eleonora Malerba, Nicola Susca, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 23
Patrizia Leone, Eleonora Malerba, Nicola Susca, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 23
Manganese Dioxide-Entrapping Dendrimers Co-Deliver Protein and Nucleotide for Magnetic Resonance Imaging-Guided Chemodynamic/Starvation/Immune Therapy of Tumors
Yue Gao, Zhijun Ouyang, Siyan Shen, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23889-23902
Closed Access | Times Cited: 38
Yue Gao, Zhijun Ouyang, Siyan Shen, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23889-23902
Closed Access | Times Cited: 38
The use of nanomaterials in advancing photodynamic therapy (PDT) for deep-seated tumors and synergy with radiotherapy
Deepak Dinakaran, Brian C. Wilson
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 24
Deepak Dinakaran, Brian C. Wilson
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 24
Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy
Megan Yuan, Wenjun Wang, Isobel Hawes, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Megan Yuan, Wenjun Wang, Isobel Hawes, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
The Use of Immune Regulation in Treating Head and Neck Squamous Cell Carcinoma (HNSCC)
Che-Wei Wang, Pulak Kumar Biswas, Atikul Islam, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 413-413
Open Access | Times Cited: 9
Che-Wei Wang, Pulak Kumar Biswas, Atikul Islam, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 413-413
Open Access | Times Cited: 9
Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
Dia Roy, Cassandra Gilmour, Sachin Patnaik, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Dia Roy, Cassandra Gilmour, Sachin Patnaik, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Human NK cells and cancer
Claudia Cantoni, Michela Falco, Massimo Vitale, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Claudia Cantoni, Michela Falco, Massimo Vitale, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Promotion of an Antitumor Immune Program by a Tumor-specific, Complement-activating Antibody
Ruchi Saxena, Ryan T. Bushey, Michael J. Campa, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 10, pp. 1589-1601
Closed Access | Times Cited: 5
Ruchi Saxena, Ryan T. Bushey, Michael J. Campa, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 10, pp. 1589-1601
Closed Access | Times Cited: 5
SAFFRON-104: a phase Ib/II study of sitravatinib alone or with tislelizumab in advanced hepatocellular carcinoma and gastric cancer/gastroesophageal junction cancer
Jin Li, Yuxian Bai, Zhendong Chen, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 11
Open Access | Times Cited: 5
Jin Li, Yuxian Bai, Zhendong Chen, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 11
Open Access | Times Cited: 5
Nanocarriers in Skin Cancer Treatment: Emerging Drug Delivery Approaches and Innovations.
L. D. Jadhav, Satish K. Mandlik
Nano TransMed (2024), pp. 100068-100068
Open Access | Times Cited: 5
L. D. Jadhav, Satish K. Mandlik
Nano TransMed (2024), pp. 100068-100068
Open Access | Times Cited: 5
Editorial: Enhancing innate immunity in combination therapy for solid tumors
David Pejoski
Frontiers in Immunology (2025) Vol. 15
Open Access
David Pejoski
Frontiers in Immunology (2025) Vol. 15
Open Access
DYNC2H1 mutation as a potential predictive biomarker for immune checkpoint inhibitor efficacy in NSCLC and melanoma
Lu Yang, Yanlong Feng, Xuewen Liu, et al.
Investigational New Drugs (2025)
Closed Access
Lu Yang, Yanlong Feng, Xuewen Liu, et al.
Investigational New Drugs (2025)
Closed Access
Dendritic cells-targeted delivery of mRNA vaccines and dual siRNAs via microneedles effectively inhibits tumor growth
Yifei Pei, Zhen Chen, Xiaoyun Wang, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106768-106768
Closed Access
Yifei Pei, Zhen Chen, Xiaoyun Wang, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106768-106768
Closed Access
In situ oxidation-responsive nanovaccine coordinates photosensitizer and STING agonist for cancer photo-immunotherapy
Zhaochu Xu, Jiang Yu, Yingxi Zhang, et al.
Nano Today (2025) Vol. 62, pp. 102726-102726
Closed Access
Zhaochu Xu, Jiang Yu, Yingxi Zhang, et al.
Nano Today (2025) Vol. 62, pp. 102726-102726
Closed Access
Fc-silent anti-TIGIT antibodies potentiate anti-tumor immunity without depleting regulatory T cells
Dana Piovesan, Amber E. de Groot, Soonweng Cho, et al.
Cancer Research (2024) Vol. 84, Iss. 12, pp. 1978-1995
Closed Access | Times Cited: 2
Dana Piovesan, Amber E. de Groot, Soonweng Cho, et al.
Cancer Research (2024) Vol. 84, Iss. 12, pp. 1978-1995
Closed Access | Times Cited: 2
Drug repurposing for cancer
Juni Banerjee, Anand Krishna Tiwari, Shuvomoy Banerjee
Progress in molecular biology and translational science (2024), pp. 123-150
Closed Access | Times Cited: 2
Juni Banerjee, Anand Krishna Tiwari, Shuvomoy Banerjee
Progress in molecular biology and translational science (2024), pp. 123-150
Closed Access | Times Cited: 2
Advancements in Immunotherapeutic Treatments for Hepatocellular Carcinoma: Potential of Combination Therapies
Yusra Zarlashat, Hafiz Salman Mushtaq, Linh Pham, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6830-6830
Open Access | Times Cited: 2
Yusra Zarlashat, Hafiz Salman Mushtaq, Linh Pham, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6830-6830
Open Access | Times Cited: 2
Advances in Cancer Nanovaccines: Harnessing Nanotechnology for Broadening Cancer Immune Response
Qian‐Ting Wang, Yixuan Liu, Jie Wang, et al.
ChemMedChem (2023) Vol. 18, Iss. 13
Closed Access | Times Cited: 6
Qian‐Ting Wang, Yixuan Liu, Jie Wang, et al.
ChemMedChem (2023) Vol. 18, Iss. 13
Closed Access | Times Cited: 6
STING Protein‐Based In Situ Vaccine Synergizes CD4+ T, CD8+ T, and NK Cells for Tumor Eradication
Yanpu He, Celestine Hong, Shengnan Huang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 24
Open Access | Times Cited: 5
Yanpu He, Celestine Hong, Shengnan Huang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 24
Open Access | Times Cited: 5
Key Determinants of Immune-Mediated Adverse Reactions to Oncology Drugs
Yihan Zhou, Shan Ding
Cancers (2023) Vol. 15, Iss. 23, pp. 5622-5622
Open Access | Times Cited: 5
Yihan Zhou, Shan Ding
Cancers (2023) Vol. 15, Iss. 23, pp. 5622-5622
Open Access | Times Cited: 5
Ganoderic acid T, a Ganoderma triterpenoid, modulates the tumor microenvironment and enhances the chemotherapy and immunotherapy efficacy through downregulating galectin-1 levels
Suyu Chen, Kuang-Dee Chen, Yihsiu Lin, et al.
Toxicology and Applied Pharmacology (2024) Vol. 491, pp. 117069-117069
Closed Access | Times Cited: 1
Suyu Chen, Kuang-Dee Chen, Yihsiu Lin, et al.
Toxicology and Applied Pharmacology (2024) Vol. 491, pp. 117069-117069
Closed Access | Times Cited: 1
Exploring the Evolving Role of Metastasectomy in Advanced Renal Cell Carcinoma
Jong Kyou Kwon, Sungun Bang, Kang Su Cho
Journal of Urologic Oncology (2024) Vol. 22, Iss. 3, pp. 228-236
Closed Access | Times Cited: 1
Jong Kyou Kwon, Sungun Bang, Kang Su Cho
Journal of Urologic Oncology (2024) Vol. 22, Iss. 3, pp. 228-236
Closed Access | Times Cited: 1
5-Hydroxytryptamine G-Protein-Coupled Receptor Family Genes: Key Players in Cancer Prognosis, Immune Regulation, and Therapeutic Response
Simeng Liu, Mingang He, Hefen Sun, et al.
Genes (2024) Vol. 15, Iss. 12, pp. 1541-1541
Open Access | Times Cited: 1
Simeng Liu, Mingang He, Hefen Sun, et al.
Genes (2024) Vol. 15, Iss. 12, pp. 1541-1541
Open Access | Times Cited: 1
